🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2024-517594-24-01
Authorised Phase I/II

CAT-01

2024-517594-24-01 · tracked via the Priya Life Science EU tracker
Sponsor
Karolinska Institutet
Sponsor type
Educational Institution
Therapeutic area
Neoplasms
Decision date
09/03/2026
Enrollment target
20
Sites
Sweden

Condition studied

Cervical carcinoma

Eligibility

Age group
65+ years, 18-64 years
Sex
Female
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2024-517594-24-01 on CTIS ↗ ← All trials in the EU